Pharmaco-metabonomic phenotyping and personalized drug treatment
T. Andrew Clayton(Imperial College London), Jeremy K. Nicholson(Imperial College London), David Baker(Quadram Institute), Jeremy R. Everett(University of Greenwich), John C. Lindon(Imperial College London), Jean-Loïc Le Net(Pfizer (France)), G. Hanton(Pfizer (France)), Claude Charuel(Pfizer (France)), Rosalind Walley(Pfizer (United Kingdom)), Olivier Cloarec, Jean-Pierre Provost(Pfizer (France)), Henrik Antti(Umeå University)
Cited by 827
Related Papers
Proposed minimum reporting standards for chemical analysis
|Metabolomics|2007|5k
'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data
|Xenobiotica|1999|3.9k
Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts
|Nature Protocols|2007|2.1k
Metabonomics: a platform for studying drug toxicity and gene function
|Nature Reviews Drug Discovery|2002|1.9k
Metabonomics
|Nature|2008|1.9k